Clinical Trial Update: A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial examining combined omeprazole and low-dose aspirin to identify colorectal cancer biomarkers for preventive efficacy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)
• Omeprazole (Omeprazole)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Colorectal Neoplasia | EARLY_Phase 1 | Status: COMPLETED